---
title: "LFCR: Q2 revenue fell 6.2% to $34.2M, but new business wins and guidance reaffirmed"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294961069.md"
description: "Q2 2026 revenue declined 6.2% year-over-year to $34.2M, with net loss widening to $6.2M. Despite lower sales, the company added 13 new programs, reaffirmed 2026 guidance, and completed multiple audits, supporting long-term growth and margin targets.Original document: Lifecore Biomedical, Inc. [LFCR] SEC 8-K Current Report — Aug. 5 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-05T11:43:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294961069.md)
  - [en](https://longbridge.com/en/news/294961069.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294961069.md)
generator: "portal-rs"
---

# LFCR: Q2 revenue fell 6.2% to $34.2M, but new business wins and guidance reaffirmed

Q2 2026 revenue declined 6.2% year-over-year to $34.2M, with net loss widening to $6.2M. Despite lower sales, the company added 13 new programs, reaffirmed 2026 guidance, and completed multiple audits, supporting long-term growth and margin targets.

Original document: Lifecore Biomedical, Inc. \[LFCR\] SEC 8-K Current Report — Aug. 5 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [LFCR.US](https://longbridge.com/en/quote/LFCR.US.md)

## Related News & Research

- [LFCR: Revenue and profit declined, with liquidity sufficient but major preferred stock redemptions looming](https://longbridge.com/en/news/294961714.md)
- [WSHP: First half 2026 results released, highlighting platform growth and ongoing user ownership initiatives](https://longbridge.com/en/news/296829514.md)
- [VER: Q2 2026 delivered 6.5% like-for-like revenue growth and strong gross margin, with 2026 guidance reaffirmed](https://longbridge.com/en/news/297124510.md)
- [SoftwareOne attaches full H1 2026 report in correction to earlier release](https://longbridge.com/en/news/297010247.md)
- [Cemat publishes H1 2026 interim report](https://longbridge.com/en/news/297006906.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**